アーフェンアデノウイルス（ゴリラ）又はアデノウイルスベクター、及び使用方法

Title:

アーフェンアデノウイルス（ゴリラ）又はアデノウイルスベクター、及び使用方法

Document Type and Number:

Japanese Patent JP6970059

Kind Code:

B2

Abstract:

The invention provides an adenovirus or adenoviral vector characterized by comprising one or more particular nucleic acid sequences or one or more particular amino acid sequences, or portions thereof, pertaining to, for example, an adenoviral pIX protein, DNA polymerase protein, penton protein, hexone protein, and/or fiber protein.

More Like This:

WO/2008/022196	DEVELOPMENT OF DENGUE VIRUS VACCINE COMPONENTS
WO/2005/080575	NUCLEIC ACID CONSTRUCT CONTAINING FULL-LENGTH GENOME OF HUMAN HEPATITIS C VIRUS, RECOMBINANT FULL-LENGTH VIRUS GENOME REPLICATIVE CELL HAVING THE NUCLEIC ACID CONSTRUCT TRANSFERRED THEREINTO AND METHOD OF CONSTRUCTING HEPATITIS C VIRAL PARTICLES
JP4813711	Attenuated human-bovine chimeric-parainfluenza virus (PIV) vaccine

Inventors:

Gull, Jason Gee Dee.
McVay, Duncan
Bluff, Douglas E.

Application Number:

JP2018137235A

Publication Date:

November 24, 2021

Filing Date:

July 20, 2018

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Genvec LRC

International Classes:

C12N7/00; A61K35/761; A61K39/235; A61K48/00; C12N15/861

Foreign References:

WO2010051367A1

Attorney, Agent or Firm:

Takashima Ichi
Mitsunori Kamata
Kyoko Doi
Yaeko Tamura
Hirofumi Toma
Atsuko Akai
Tomiya Tozaki
Kamei Keijiro

Previous Patent: Arithmetic logic unit

Next Patent: Afen adenovirus (gorilla) or adenovirus vector, and how to use